Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT02067091

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02067091
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark, Norway (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02067091. Randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2018-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct
Acronym
BVS in STEMI
Condition
Acute ST Segment Elevation Myocardial Infarction
Intervention (Device)
stent implant in a coronary artery
Lead sponsor
Haukeland University Hospital (class: other)
Collaborator
Aarhus University Hospital Skejby (class: other)
Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (class: other)
Collaborator
Oslo University Hospital (class: other)
Collaborator
St. Olavs Hospital (class: other)
Collaborator
University Hospital of North Norway (class: other)
Collaborator
Feiring (class: not stated)

Record details

Record id
cardio:ct-nct02067091
Content hash
6c6ac8de2cdf2f05f4566e10efb5a822d6de46db36414b2219561032c56dc0d9